Cargando…

Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study

BACKGROUND AND OBJECTIVE: Prescribing inhaled corticosteroids (ICS) for bronchiectasis (BE) in the absence of obstructive lung disease is controversial. Studies investigating ICS therapy and impact on morbidity and mortality in BE are sparse. METHODS: This study comprises all patients with BE manage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Håkansson, Kjell E J, Fjaellegaard, Katrine, Browatzki, Andrea, Dönmez Sin, Melda, Ulrik, Charlotte Suppli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291380/ https://www.ncbi.nlm.nih.gov/pubmed/34295156 http://dx.doi.org/10.2147/COPD.S311236

Ejemplares similares

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
por: Renzi-Lomholt, Martino, et al.
Publicado: (2022)

Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
por: Jensen, Frodi Fridason, et al.
Publicado: (2021)

A causal relationship between rheumatoid arthritis and bronchiectasis? A systematic review and meta-analysis
por: Wiater, Rafal, et al.
Publicado: (2021)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

Determining Persistence with an Inhaled Corticosteroid in Asthma: Assessment Using an Objective Measurement vs the Self-Reported Foster Score
por: Hedegaard, Britt Overgaard, et al.
Publicado: (2022)

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
por: Martinez-Garcia, Miguel Angel
Publicado: (2023)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
por: Savran, Osman, et al.
Publicado: (2023)

COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
por: Savran, Osman, et al.
Publicado: (2019)

Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
por: Henkle, Emily, et al.
Publicado: (2022)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
por: Savran, Osman, et al.
Publicado: (2021)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Socioeconomic status is associated with healthcare seeking behaviour and disease burden in young adults with asthma – A nationwide cohort study
por: Håkansson, Kjell Erik Julius, et al.
Publicado: (2022)

Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma – A Nationwide Cohort Study
por: Håkansson, Kjell Erik Julius, et al.
Publicado: (2022)

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
por: Mosbech, Christiane Hammershaimb, et al.
Publicado: (2023)

Demographic, lifestyle and comorbid risk factors for all-cause mortality in a Danish cohort of middle-aged adults with incident asthma
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2021)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023)

High Use of Antidepressant Medication in Both Mild-to-Modelate and Possible Severe Asthma – A Nationwide Cohort Study
por: Håkansson, Kjell Erik Julius, et al.
Publicado: (2022)

Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better
por: Gregersen, Thorbjørn Lomholt, et al.
Publicado: (2013)

Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
por: Martínez-García, Miguel Ángel, et al.
Publicado: (2022)

Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study
por: Nielsen, Anne Orholm, et al.
Publicado: (2021)

Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort
por: Håkansson, Kjell Erik Julius, et al.
Publicado: (2023)

Childhood Asthma and Parental Antidepressant Use in a Nationwide Danish Cohort
por: Cabrera Guerrero, Silvia, et al.
Publicado: (2023)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Beyond direct costs: individual and societal financial burden of asthma in young adults in a Danish nationwide study
por: Håkansson, Kjell Erik Julius, et al.
Publicado: (2023)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis
por: Sin, Sooim, et al.
Publicado: (2019)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
por: Soltani, Amir, et al.
Publicado: (2016)

Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study
por: Choi, Hayoung, et al.
Publicado: (2020)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016)

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
por: Singh, Dave, et al.
Publicado: (2020)

Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2021)

Does inhaled corticosteroid use affect the risk of  COVID-19-related death?
por: Jordan, Alexander, et al.
Publicado: (2021)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Inhaled Corticosteroids and Bone Health
por: Chee, Carolyn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lhjn9okmn1f6kmcko4mtnru0mp